Edition:
United States

AquaBounty Technologies Inc (AQB.OQ)

AQB.OQ on NASDAQ Stock Exchange Capital Market

3.08USD
16 Aug 2019
Change (% chg)

$0.01 (+0.33%)
Prev Close
$3.07
Open
$3.10
Day's High
$3.13
Day's Low
$3.06
Volume
4,020
Avg. Vol
36,139
52-wk High
$5.44
52-wk Low
$1.55

Latest Key Developments (Source: Significant Developments)

Aquabounty Technologies Says Public Offering Of 2.55 Mln Common Shares Priced At $2.25 Per Share
Tuesday, 9 Apr 2019 04:00pm EDT 

April 9 (Reuters) - AquaBounty Technologies Inc ::AQUABOUNTY TECHNOLOGIES, INC. ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 2.55 MILLION COMMON SHARES PRICED AT $2.25PER SHARE.  Full Article

AquaBounty Technologies Says Public Offering Of 2.55 Mln Shares Priced At $2.25/Share
Thursday, 4 Apr 2019 09:55pm EDT 

April 4 (Reuters) - AquaBounty Technologies Inc ::AQUABOUNTY TECHNOLOGIES, INC. ANNOUNCES PRICING OF $5.75 MILLION PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 2.55 MILLION COMMON SHARES PRICED AT $2.25PER SHARE.  Full Article

Aquabounty Technologies Announces Proposed Public Offering Of Common Stock
Thursday, 4 Apr 2019 04:08pm EDT 

April 4 (Reuters) - AquaBounty Technologies Inc ::AQUABOUNTY TECHNOLOGIES, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.AQUABOUNTY TECHNOLOGIES - TO USE PROCEEDS OF OFFERING FOR CAPITAL COSTS ASSOCIATED WITH GROWING FIRST BATCHES OF FISH AT INDIANA, ROLLO BAY FARM SITES.  Full Article

Aquabounty Technologies, Inc. Announces Closing Of Public Offering Of Common Stock
Thursday, 21 Mar 2019 04:02pm EDT 

AquaBounty Technologies Inc ::AQUABOUNTY TECHNOLOGIES, INC. ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 3.35 MILLION COMMON SHARES PRICED AT $2.25PER SHARE.  Full Article

Aquabounty Technologies Announces Pricing Of $7.5 Million Public Offering Of Common Stock
Tuesday, 19 Mar 2019 07:14am EDT 

March 19 (Reuters) - AquaBounty Technologies Inc ::AQUABOUNTY TECHNOLOGIES ANNOUNCES PRICING OF $7.5 MILLION PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 3.35 MILLION COMMON SHARES PRICED AT $2.25PER SHARE.  Full Article

Aquabounty Technologies Announces Proposed Public Offering Of Common Stock
Tuesday, 19 Mar 2019 06:01am EDT 

March 19 (Reuters) - AquaBounty Technologies Inc ::AQUABOUNTY TECHNOLOGIES, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 3.35 MILLION COMMON SHARES PRICED AT $2.25PER SHARE.  Full Article

AquaBounty Technologies Announces Proposed Public Offering Of Common Stock
Monday, 18 Mar 2019 04:00pm EDT 

March 18 (Reuters) - AquaBounty Technologies Inc ::AQUABOUNTY TECHNOLOGIES, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.  Full Article

Aquabounty Technologies - Will Immediately Start Process To Import Aquadvantage Eggs From Hatchery In Canada To Begin Grow Out At Indiana Facility
Friday, 8 Mar 2019 03:18pm EST 

March 8 (Reuters) - AquaBounty Technologies Inc ::AQUABOUNTY TECHNOLOGIES - WILL IMMEDIATELY START PROCESS TO IMPORT AQUADVANTAGE EGGS FROM HATCHERY IN CANADA TO BEGIN GROW OUT AT INDIANA FACILITY.  Full Article

FDA Says Deactivating Import Alert on GE Salmon
Friday, 8 Mar 2019 12:45pm EST 

March 8 (Reuters) - U.S. FDA:U.S. FDA SAYS DEACTIVATING A 2016 IMPORT ALERT THAT PREVENTED GE SALMON FROM ENTERING THE U.S..U.S. FDA SAYS DETERMINED THAT GE ATLANTIC SALMON MET STATUTORY REQUIREMENTS FOR SAFETY, EFFECTIVENESS UNDER FEDERAL FOOD, DRUG, AND COSMETIC ACT.U.S. FDA SAYS DEACTIVATING IMPORT ALERT THAT PREVENTED FOOD FROM AQUADVANTAGE SALMON, INCLUDING SALMON EGGS USED TO GROW FISH, FROM ENTERING U.S..  Full Article

Intrexon And Aquabounty Receive Regulatory Exemption In Development Of Gene Edited Tilapia For More Sustainable Production
Tuesday, 18 Dec 2018 07:30am EST 

Dec 18 (Reuters) - AquaBounty Technologies Inc ::INTREXON AND AQUABOUNTY RECEIVE REGULATORY EXEMPTION IN DEVELOPMENT OF GENE EDITED TILAPIA FOR MORE SUSTAINABLE PRODUCTION.INTREXON CORP - FLT 01, IS EXEMPT FROM GM REGULATION ACCORDING TO ARGENTINA'S NATIONAL ADVISORY COMMISSION ON AGRICULTURAL BIOTECHNOLOGY.  Full Article